Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: FIS stock price vs BHC: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at BHC's multiple
Needs BHC P/E.
Implied fair value · at FIS's multiple
Needs FIS P/E.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: FIS FY 2025 (ended Dec 31, 2025) · BHC FY 2025 (ended Dec 31, 2025).
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Fidelity National Information Services, Inc. · implied price per share
Bear
$19.94
Base
$25.38
Bull
$35.04
Bausch Health Companies Inc. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
0.84x
-37.98x
Net debt / EBITDA
Leverage against operating earnings
6.52x
8.15x
Cash and equivalents
Liquid reserves on the balance sheet
$599.00M
$1.31B
Total debt
Interest-bearing obligations outstanding
$11.64B
$21.04B
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
JACK HENRY & ASSOCIATES INC
FIS vs JKHY
GLOBAL PAYMENTS INC
FIS vs GPN
FISERV INC
FIS vs FI
BROADRIDGE FINANCIAL SOLUTIONS, INC.
FIS vs BR
AbbVie Inc.
FIS vs ABBV
Organon & Co.
FIS vs OGN
TEVA PHARMACEUTICAL INDUSTRIES LTD
FIS vs TEVA
SUPERNUS PHARMACEUTICALS, INC.
FIS vs SUPN
ANI PHARMACEUTICALS INC
FIS vs ANIP
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
